Auren Rx Tirzepatide Review: $299 Month-to-Month, $259 Subscribed (2026)

Auren Rx sells compounded tirzepatide at $299 a month with no commitment, or $259 a month if you subscribe, and it prints both numbers on the same page. There is a second tirzepatide tier — a microdose program at $250 no-commitment, $229 subscribed — with its own page, its own intake and its own rungs. That is a complete tirzepatide ladder with a real monthly option at the top of it, which is rarer than it sounds. This page carries no outbound link; every figure below was read out of Auren Rx's own front-end bundle and cross-checked against its rendered product pages in August 2026.

The tirzepatide rungs

Semaglutide sits at $199 no-commitment and $169 subscribed on the standard program, $149 and $129 on the microdose one. The figure we file for Auren Rx is $299, because that is what tirzepatide costs if you want to be able to stop, and because the subscribe rung is a discount for a commitment rather than a price.

There is no prepay tier at all on this site — no three-month total, no annual plan — so there is no prepay-as-monthly arithmetic to unpick. Billing runs approximately every 28 to 30 days, which is fractionally short of a calendar month, and Auren Rx says so in its terms. Undisclosed four-week billing is how a "$199/month" plan quietly becomes thirteen charges a year; disclosed four-week billing is just a fact about the cadence.

Two ways to write down the wrong number here

The page opens on tirzepatide. The weight-loss product loads with the tirzepatide variant already selected rather than semaglutide. On most sites the shifted-column error runs the other way and a semaglutide price gets filed under tirzepatide; here, a careless capture takes $299 off the screen and records it as "what Auren Rx costs." It is what Auren Rx costs for tirzepatide. If you are comparing this against a semaglutide plan somewhere else, you are $100 a month out.

The structured data publishes the subscription price. Auren Rx's own product markup emits $169 and $259 — the subscribe rungs — as the offer price. Anything that reads a page's machine-readable data instead of its rendered table will publish those. Both are genuine prices; neither is the no-commitment one. If you find Auren Rx quoted at $259 for tirzepatide somewhere, that is where it came from.

And the navigation says "from $129." That $129 is the microdose semaglutide subscribe rung, sitting under a heading that reads as GLP-1 generally. It is not an invented number, but the cheapest standard GLP-1 rung is $169 subscribed and $199 monthly, and there is no tirzepatide rung within $100 of it. Nothing about that navigation label is useful for pricing tirzepatide.

The microdose program is a real program

Plenty of telehealth sellers mention microdosing; Auren Rx runs it as a named product with a separate page, a separate intake flow and a four-rung price table across both molecules. Tirzepatide microdosing is $250 a month with no commitment, $229 subscribed — a $49 saving against the standard program, not a different drug. Structurally that is a commitment rather than a marketing line, and it is the strongest reason to look here if low-dose is specifically what you want. The standing caveat applies regardless of who sells it: no randomized trial has tested below-label tirzepatide dosing for any outcome, and the dose-response data we do have runs the other way — see our tirzepatide dosage chart for what the approved ladder is built on.

The rest of the shelf

Ten products, and the NAD+ line is the most granular we have cataloged: seven rungs across injection, nasal spray and cream, each with its strength and volume stated, from $155 a month for the small cream to $249 for the 300 mg/mL nasal 30 mL. Sermorelin is $199 monthly, glutathione $119 injectable and $109 nasal, GHK-Cu cream $109, tretinoin $49, oral minoxidil $49, valacyclovir $39 to $49, estradiol $69 to $99 — all month-to-month figures.¹ There is no research-chemical shelf, no retatrutide, no melanotan, no testosterone, which puts it in cleaner company than Pepti or Rehydra+ Wellness.

Two of those ten — valacyclovir and estradiol — do not appear in the site's own sitemap. Reading the sitemap alone would tell you they do not exist.

The hole in the disclosure

Auren Rx never says which states it serves. Its terms refer to services being available to people located in "certain states" and in "a state where we operate," and no list appears anywhere — not on a product page, not in the terms, not in a footer, not in a help center. Every other provider we looked at in this batch either publishes an enumerated list or claims all fifty. You will not find out whether your state qualifies until you are inside the intake.

The pharmacy is not named either — it is described as Auren RX or a partner within its pharmacy network. You may elect a local pharmacy of your own instead, in which case the membership fee excludes the medication cost, which is an unusual and genuinely useful option. Clinical services are attributed to Beluga Health, P.A., a real telehealth professional association, though no individual prescriber and no NPI is published. The corporate entity is Hades Capital LLC, trading as Auren RX, with no published address.

Product pages carry 4.6 to 4.9 star ratings with no review count and no source behind them. We do not repeat those.

Fees and getting out

The membership fee is charged the day membership commences and is non-refundable once paid. The detail that matters: membership begins after a provider has communicated a care plan and you have elected to proceed, so the charge follows clinical review rather than preceding it. That is the better order, and it is not the order Rehydra+ Wellness or Lighter You use. Cancellation is month-to-month by email or in-account, fees already paid are not refunded, and membership can be paused with no further charges until you order a refill.

The regulatory screen

The trading name, the legal entity, the medical group and the platform vendor all returned zero company-column matches in the FDA's live warning-letter index in August 2026.² The pass carried a positive control that correctly returned a real February 2026 letter to an unrelated telehealth seller on every run,³ so the zero is a finding and not a query that failed quietly.

Brand versus compounded

Compounded tirzepatide, not Zepbound: pharmacy-made, not an FDA-approved finished drug, and not what the pivotal trials tested. See is compounded tirzepatide still legal in 2026. The molecule's evidence — about 15% to 21% average body-weight loss over 72 weeks in SURMOUNT-1⁴ and about 20% against semaglutide's 14% in SURMOUNT-5⁵ — is in our tirzepatide evidence guide, and belongs to the brand product at approved doses.

The honest verdict

As a price surface, Auren Rx is the best-built thing in this batch: a no-commitment rung printed beside a subscribe rung on every single product, a genuine microdose tier with its own ladder, a disclosed billing cadence, and no prepay tier to disguise anything. $299 a month for tirzepatide is above the middle of our ranking — Trellis Vitality is $100 less for the same molecule with no commitment either — so you are not buying it for the number. You are buying it for a company that shows you both prices instead of one. Against that: you cannot find out whether it serves your state without starting an intake, and you cannot find out who compounds your medication at all. Those are not small, and on a purchase you will repeat monthly they are worth an email before a card. Compare the rung against the field in our tirzepatide price index or the ranked best tirzepatide providers ranking.